KYMR logo

Kymera Therapeutics (KYMR) Accounts payable

annual accounts payable:

$5.99M-$1.09M(-15.35%)
December 31, 2024

Summary

  • As of today (July 1, 2025), KYMR annual accounts payable is $5.99 million, with the most recent change of -$1.09 million (-15.35%) on December 31, 2024.
  • During the last 3 years, KYMR annual accounts payable has risen by +$1.98 million (+49.54%).
  • KYMR annual accounts payable is now -15.35% below its all-time high of $7.08 million, reached on December 31, 2023.

Performance

KYMR Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

quarterly accounts payable:

$10.26M+$4.27M(+71.36%)
March 31, 2025

Summary

  • As of today (July 1, 2025), KYMR quarterly accounts payable is $10.26 million, with the most recent change of +$4.27 million (+71.36%) on March 31, 2025.
  • Over the past year, KYMR quarterly accounts payable has increased by +$3.45 million (+50.66%).
  • KYMR quarterly accounts payable is now at all-time high.

Performance

KYMR quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

KYMR Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-15.3%+50.7%
3 y3 years+49.5%+299.8%
5 y5 years+82.8%-

KYMR Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-15.3%+49.5%at high+332.3%
5 y5-year-15.3%+82.8%at high+332.3%
alltimeall time-15.3%+191.3%at high+332.3%

KYMR Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$10.26M(+71.4%)
Dec 2024
$5.99M(-15.3%)
$5.99M(-7.8%)
Sep 2024
-
$6.49M(-0.2%)
Jun 2024
-
$6.51M(-4.4%)
Mar 2024
-
$6.81M(-3.7%)
Dec 2023
$7.08M(+63.2%)
$7.08M(+42.1%)
Sep 2023
-
$4.98M(+32.9%)
Jun 2023
-
$3.75M(-42.2%)
Mar 2023
-
$6.48M(+49.6%)
Dec 2022
$4.33M
$4.33M(-31.5%)
Sep 2022
-
$6.33M(+166.5%)
DateAnnualQuarterly
Jun 2022
-
$2.37M(-7.5%)
Mar 2022
-
$2.57M(-35.9%)
Dec 2021
$4.00M(-8.3%)
$4.00M(-20.4%)
Sep 2021
-
$5.03M(-38.4%)
Jun 2021
-
$8.18M(-2.0%)
Mar 2021
-
$8.35M(+91.1%)
Dec 2020
$4.37M(+33.3%)
$4.37M(+9.8%)
Sep 2020
-
$3.98M(-0.1%)
Jun 2020
-
$3.98M(+21.6%)
Dec 2019
$3.28M(+59.3%)
$3.28M
Dec 2018
$2.06M
-

FAQ

  • What is Kymera Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Kymera Therapeutics?
  • What is Kymera Therapeutics annual accounts payable year-on-year change?
  • What is Kymera Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Kymera Therapeutics?
  • What is Kymera Therapeutics quarterly accounts payable year-on-year change?

What is Kymera Therapeutics annual accounts payable?

The current annual accounts payable of KYMR is $5.99M

What is the all time high annual accounts payable for Kymera Therapeutics?

Kymera Therapeutics all-time high annual accounts payable is $7.08M

What is Kymera Therapeutics annual accounts payable year-on-year change?

Over the past year, KYMR annual accounts payable has changed by -$1.09M (-15.35%)

What is Kymera Therapeutics quarterly accounts payable?

The current quarterly accounts payable of KYMR is $10.26M

What is the all time high quarterly accounts payable for Kymera Therapeutics?

Kymera Therapeutics all-time high quarterly accounts payable is $10.26M

What is Kymera Therapeutics quarterly accounts payable year-on-year change?

Over the past year, KYMR quarterly accounts payable has changed by +$3.45M (+50.66%)
On this page